Skin toxicities are common with targeted therapies for GI malignancies but can be remedied by preventive measures and a collaboration with dermatology.
Rona Yaeger, MD
Advertisement
Articles by Rona Yaeger, MD
Advertisement
Latest Updated Articles
Identifying Common Toxicities With Targeted Therapies in GI MalignanciesPublished: November 16th 2025 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Spotlighting the Top 10 FDA Oncology Approvals in 2025
2
Nab-Sirolimus Regimens Show Promise in HR+/HER2-Negative Breast Cancer
3
Ivosidenib Combo Shows Preliminary Activity in IDH1-Mutated AML
4
What’s New in Hematology/Oncology? Discussing the 2025 ASH Annual Meeting
5